KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to 0.03%.

  • Pacira BioSciences' Return on Capital Employed rose 800.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.06% for FY2024, which is 1200.0% down from last year.
  • Pacira BioSciences' Return on Capital Employed amounted to 0.03% in Q3 2025, which was up 800.0% from 0.08% recorded in Q2 2025.
  • Pacira BioSciences' 5-year Return on Capital Employed high stood at 0.09% for Q3 2021, and its period low was 0.08% during Q2 2025.
  • Its 5-year average for Return on Capital Employed is 0.03%, with a median of 0.05% in 2022.
  • The largest annual percentage gain for Pacira BioSciences' Return on Capital Employed in the last 5 years was 800bps (2025), contrasted with its biggest fall of -1400bps (2025).
  • Pacira BioSciences' Return on Capital Employed (Quarter) stood at 0.08% in 2021, then tumbled by -49bps to 0.04% in 2022, then soared by 56bps to 0.06% in 2023, then plummeted by -199bps to 0.06% in 2024, then skyrocketed by 153bps to 0.03% in 2025.
  • Its Return on Capital Employed was 0.03% in Q3 2025, compared to 0.08% in Q2 2025 and 0.07% in Q1 2025.